Professional
Added to YB: 2024-09-18
Pitch date: 2024-09-16
SRT.F [bullish]
Sartorius Aktiengesellschaft
+2.04%
current return
Author Info
No bio for this author
Company Info
Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors; software apps for bioreactors and cell culture shake flasks; fermenters; cell culture media, biolayer interferometry, microbiological testing, and fluid management products; buffers; reagents; plasmids; cellcelector flexs, incubator flowboxes, nanowell arrays, and capillaries and tips; high-throughput screening by cytometry; ultrafiltration solutions; syringe, membrane, glass and quartz microfiber, clarification, syringeless, and in-line filters; and lab chromatography, and filters and blotting papers.
Market Cap
EUR 11.7B
Pitch Price
EUR 185.61
Price Target
N/A
Dividend
0.39%
EV/EBITDA
21.83
P/E
154.33
EV/Sales
4.91
Sector
Life Sciences Tools and Services
Category
turnaround
RGA Investment Advisors Portfolio Holding: Sartorius Aktiengesellschaft
SRT.F: Bioprocessing firm facing challenges meeting guidance, leading to share price decline. Post-COVID bottom established, industry inflection point begun. Debate over return to normalized growth, but structural growth unchanged. Long-term returns from cost basis expected to meet or exceed initial projections.
Read full article (1 min)